Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists.

Bicyclic piperazine derivatives were synthesized as conformationally constrained analogs of N-alkyl piperazines and were found to be potent CB1 receptor agonists. The CB1 receptor agonist activity was dependent upon the absolute configuration of the chiral center of the bicyclic ring system. Although the conformational constraint did not protect the compounds from metabolism by N-dealkylation, several bicyclic analogs were found to be more potent than the unconstrained lead compound. Compound 8b demonstrated potent antinociceptive activity in vivo.

[1]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[2]  R. Morphy,et al.  Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists , 2010 .

[3]  L. Padgett,et al.  Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. , 2005, Current medicinal chemistry.

[4]  P. Goya,et al.  CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications. , 2008, Current topics in medicinal chemistry.

[5]  Annick Lauwers,et al.  Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development. , 2009, Mutation research.

[6]  W. Bowen,et al.  Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at sigma receptors. 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds. , 1993, Journal of medicinal chemistry.

[7]  Ken Mackie,et al.  Cannabinoid receptors as therapeutic targets. , 2006, Annual review of pharmacology and toxicology.

[8]  S. Oh,et al.  Property based optimization of δ-lactam HDAC inhibitors for metabolic stability. , 2010, Bioorganic & medicinal chemistry letters.

[9]  Alexandros Makriyannis,et al.  Latest advances in cannabinoid receptor agonists , 2009, Expert opinion on therapeutic patents.

[10]  G. Walker,et al.  Design, synthesis, and structure-activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists. , 2010, Bioorganic & medicinal chemistry letters.

[11]  F. Bermúdez-Silva,et al.  The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning? , 2010, Pharmacology Biochemistry and Behavior.

[12]  R. Pertwee.  Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development , 2000, Expert opinion on investigational drugs.

[13]  A. Christopoulos,et al.  Allosteric Modulation of the Cannabinoid CB1 Receptor , 2005, Molecular Pharmacology.